Industry: Healthcare
Investor: China Private Equity
Invested: April 2008
Frontage is a leading U.S. - China Contract Research Organization (“CRO”) that provides research services to facilitate pharmaceutical discovery, development and commercialization for large and emerging pharmaceutical and biotechnology companies. The Company has facilities in Pennsylvania (Malvern and Exton) and in China (Shanghai).